Lp-PLA2, scavenger receptor class B type i gene (SCARB1) rs10846744 variant, and cardiovascular disease

Ani Manichaikul, Xin Qun Wang, Li Li, Jeanette Erdmann, Guillaume Lettre, Joshua C. Bis, Dawn Waterworth, Mary Cushman, Nancy S. Jenny, Wendy S. Post, Walter Palmas, Michael Y. Tsai, Lars Wallentin, Harvey White, Heribert Schunkert, Christopher J. O'Donnell, David M. Herrington, Stephen S. Rich, Michelle L. O'Donoghue, Annabelle Rodriguez

Research output: Contribution to journalArticle

Abstract

Background We previously reported association of SCARB1 SNP rs10846744 with common carotid IMT (cIMT) and cardiovascular disease (CVD) events. Since rs10846744 has been reported in association with Lp-PLA2 mass and activity, we hypothesized that inflammatory pathways might mediate the association of rs10846744 with atherosclerosis. Methods We first examined association of rs10846744 in CVD in multiple large-scale consortiumbased genome-wide association studies. We further examined 27 parameters of interest, including Lp-PLA2 mass and activity, inflammatory markers, and plasma phospholipid fatty acids, and fatty acid ratios in participants from the Multi-Ethnic Study of Atherosclerosis (MESA), as potential mediators in the pathway linking rs10846744 with cIMT and incident CVD. Finally, we examined the association of rs10846744 with Lp-PLA2 activity, cardiovascular outcomes, and interaction with the Lp-PLA2 inhibitor, darapladib, in the Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy (STABILITY) and Stabilization of Plaque using Darapladib-Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) studies. Results SCARB1 rs10846744 was associated with coronary artery disease events in CARDIo-GRAMplusC4D (odds ratio 1.05; 95% CI [1.02, 1.07]; P = 1.4x10-4). In combined analysis across race/ethnic groups in MESA, rs10846744 was associated with Lp-PLA2 mass (P = 0.04) and activity (P = 0.001), homocysteine (P = 0.03), LDL particle number (P = 0.01), docosahexaenoic acid [DHA] (P = 0.01), docosapentaenoic acid [DPA] (P = 0.04), DPA/ eicosapentaenoic acid [EPA] ratio (P = 0.002), and DHA/EPA ratio (P = 0.008). Lp-PLA2 activity was identified as a mediator of rs10846744 with cIMT in a basic model (P = 8x10-5), but not after adjustment for CVD risk factors. There was no interaction or modifier effect of the Lp-PLA2 inhibitor darapladib assignment on the relationship between rs10846744 and major CVD events in either STABILITY or SOLID-TIMI 52. Summary SCARB1 rs10846744 is significantly associated with Lp-PLA2 activity, atherosclerosis, and CVD events, but Lp-PLA2 activity is not a mediator in the association of rs10846744 with cIMT in MESA.

Original languageEnglish (US)
Article numbere0204352
JournalPloS one
Volume13
Issue number10
DOIs
StatePublished - Oct 2018

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • General

Fingerprint Dive into the research topics of 'Lp-PLA<sub>2</sub>, scavenger receptor class B type i gene (SCARB1) rs10846744 variant, and cardiovascular disease'. Together they form a unique fingerprint.

  • Cite this

    Manichaikul, A., Wang, X. Q., Li, L., Erdmann, J., Lettre, G., Bis, J. C., Waterworth, D., Cushman, M., Jenny, N. S., Post, W. S., Palmas, W., Tsai, M. Y., Wallentin, L., White, H., Schunkert, H., O'Donnell, C. J., Herrington, D. M., Rich, S. S., O'Donoghue, M. L., & Rodriguez, A. (2018). Lp-PLA2, scavenger receptor class B type i gene (SCARB1) rs10846744 variant, and cardiovascular disease. PloS one, 13(10), [e0204352]. https://doi.org/10.1371/journal.pone.0204352